Video Latest - ecancer

Rituximab after ASCT prolongs survival for young MCL patients

Prof Steven Le Gouill - Nantes Medical University, Nantes, France

5 Dec 2016

Highlights in myeloid leukaemia research from ASH 2016

Dr Luca Mazzarella - European Institute of Oncology, Milan, Italy

5 Dec 2016

Thromboembolytic risks of central venous catheters in paediatric patients

Dr Julie Jaffray - Children's Center for Cancer, Los Angeles, USA

5 Dec 2016

Pure erythroid leukaemias

Dr Guillermo Montalbán Bravo - MD Anderson Cancer Center, Houston, USA

5 Dec 2016

Clinical updates for guadecitabine and vorinostat

Dr Guillermo Montalbán Bravo - MD Anderson Cancer Center, Houston, USA

5 Dec 2016

Pracinostat and azacitidine for elderly AML

Prof Guillermo Garcia-Manero - MD Anderson Cancer Center, Houston, USA

5 Dec 2016

Ineligibility required for 'anti-trials': inclusion in studies regardless of fitness

Prof Guillermo Garcia-Manero - MD Anderson Cancer Center, Houston, USA

5 Dec 2016

Vosaroxin for relapsed AML: Updates from VALOR

Dr Farhad Ravandi - MD Anderson Cancer Center, Houston, USA

5 Dec 2016

Obinutuzumab extends PFS for follicular lymphoma in GALLIUM trial

Dr Andrew Davies - University of Southampton, Southampton, UK

4 Dec 2016

Venetoclax plus cytarabine in elderly AML patients

Dr Andrew Wei - Alfred Hospital, Melbourne, Australia

4 Dec 2016

Intravenous or subcutaenous rituximab for FL in the SABRINA study

Dr Andrew Davies - University of Southampton, Southampton, UK

4 Dec 2016

Ibrutinib in CLL: RESONATE and resistance

Dr Jennifer Woyach - The Ohio State University Medical Center, Columbus, USA

4 Dec 2016

Video